Key result
Adding tirofiban to PCI boosts normal myocardial perfusion to ~93% versus PCI alone.
Why the study?
The study was conducted to investigate the therapeutic effect of tirofiban hydrochloride sodium chloride injection combined with cardiovascular intervention on acute myocardial infarction.
Does tirofiban hydrochloride combined with PCI improve myocardial perfusion and reduce adverse cardiac events in patients with acute myocardial infarction?
RCT (n=84)
Random number table method
No
Does tirofiban hydrochloride combined with PCI improve myocardial perfusion and reduce adverse cardiac events in patients with acute myocardial infarction?
Tirofiban combined with PCI significantly improves myocardial perfusion and reduces adverse cardiac events in patients with acute myocardial infarction.
Supports adjunctive tirofiban post-PCI in AMI for higher perfusion rates; confirms benefit in this RCT.
Objective: To investigate the therapeutic effect of tirofiban hydrochloride sodium chloride injection combined with cardiovascular intervention on acute myocardial infarction. Methods: Eighty-four patients with acute myocardial infarction who were treated in our hospital from April 2017 to May 2018 were divided into a control group and a treatment group using random number table method; there were 42 patients in each group. Both groups were given conventional treatment and were treated with aspirin and clopidogrel before and after operation. Moreover, the control group was treated with cardiovascular interventional therapy, while the treatment group was treated with tirofiban hydrochloride on the basis of cardiovascular interventional therapy. The patients were followed up to observe and compare the treatment condition and adverse reactions of the two groups. Results: After percutaneous coronary intervention, the normal rate of myocardial perfusion in the treatment group was 92.86%, which was higher than 69.05% in the control group (P<0.05). After PCI, there were significant differences of thrombolysis in myocardial infarction (TIMI) flow Grade- 2 and 3 between the two groups (P<0.05). The improvement of platelet activation function in the treatment group was better than that in the control group (P<0.05). The incidence of adverse cardiac events in the treatment group was significantly lower than that in the control group (P<0.05). Conclusion: Tirofiban hydrochloride sodium chloride injection combined with cardiovascular intervention has a significant clinical effect in the treatment of acute myocardial infarction. It can effectively improve the blood perfusion and reduce the incidence of adverse cardiac events, suggesting a good effect on the prognosis of patients and high application value. doi: https://doi.org/10.12669/pjms.36.2.1005 How to cite this:Liu Y, Zhang L, Yang Y. Tirofiban hydrochloride sodium chloride injection combined with cardiovascular intervention in the treatment of Acute Myocardial Infarction. Pak J Med Sci. 2020;36(2):54-58. doi: https://doi.org/10.12669/pjms.36.2.1005 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2019) conducted an RCT in Acute Myocardial Infarction (n=84). Tirofiban hydrochloride sodium chloride injection vs. Conventional treatment and cardiovascular intervention (PCI) alone was evaluated on Normal rate of myocardial perfusion (TMPG Grade-III) after PCI (p=<0.05). Tirofiban hydrochloride combined with cardiovascular intervention significantly increased the normal rate of myocardial perfusion to 92.86% compared to 69.05% with intervention alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: